Abstract
Bumetanide is an effective diuretic for the treatment of ascites. Fifteen out of 17 patients with chronic liver disease responded satisfactorily and the incidence of hepatic encephalopathy and electrolyte disturbances was similar to that previously observed with frusemide. Colicky abdominal pain was reported in three patients but no other adverse effects were noted. An unexpected response was obtained in two patients who had diuresis without natriuresis.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Asbury M. J., Gatenby P. B., O'Sullivan S., Bourke E. Bumetanide: potent new "loop" diuretic. Br Med J. 1972 Jan 22;1(5794):211–213. doi: 10.1136/bmj.1.5794.211. [DOI] [PMC free article] [PubMed] [Google Scholar]
- CASEY T. H., SUMMERSKILL W. H., ORVIS A. L. BODY AND SERUM POTASSIUM IN LIVER DISEASE. I. RELATIONSHIP TO HEPATIC FUNCTION AND ASSOCIATED FACTORS. Gastroenterology. 1965 Feb;48:198–207. [PubMed] [Google Scholar]
- Harrington J. T., Cohen J. J. Clinical disorders of urine concentration and dilution. Arch Intern Med. 1973 Jun;131(6):810–825. [PubMed] [Google Scholar]
- Olesen K. H., Sigurd B., Steiness E., Leth A. Bumetanide, a new potent diuretic. A clinical evaluation in congestive heart failure. Acta Med Scand. 1973 Jan-Feb;193(1-2):119–131. [PubMed] [Google Scholar]
- Sherlock S., Senewiratne B., Scott A., Walker J. G. Complications of diuretic therapy in hepatic cirrhosis. Lancet. 1966 May 14;1(7446):1049–1052. doi: 10.1016/s0140-6736(66)91005-1. [DOI] [PubMed] [Google Scholar]